| Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC) (NCT06943235) | Fudan University | 2025-04-25 |
| Breast Cancer PET/CT Imaging With 68Ga-pAKTi (NCT06943313) | Fudan University | 2025-04-21 |
| RGL-305+ Lymphoma + Exploratory Clinical Study (NCT07006012) | Fudan University | 2025-04-21 |
| TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC (NCT06914297) | Fudan University | 2025-04-21 |
| MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC (NCT07235566) | Fudan University | 2025-04-21 |
| Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer (NCT06934018) | Fudan University | 2025-04-21 |
| Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases (NCT07134153) | Fudan University | 2025-04-18 |
| Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma (NCT06914687) | Fudan University | 2025-04-15 |
| Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors (NCT06713148) | Fudan University | 2025-04-10 |
| Neoadjuvant SNF Precision Therapy Phase III (NCT06913777) | Fudan University | 2025-04-08 |
| Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy (NCT07574749) | Fudan University | 2025-04-07 |
| HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer (NCT06849492) | Fudan University | 2025-04-01 |
| A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer (NCT07562490) | Fudan University | 2025-04-01 |
| Lung Atelectasis Improvement Through Positive End Expiratory Pressure During Anesthetic Induction (NCT06900426) | Fudan University | 2025-03-28 |
| Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas (NCT06914674) | Fudan University | 2025-03-20 |
| Cryoablation Combined With Lenvatinib Plus Tislelizumab Compared With FOLFOX in Patients With Advanced Intrahepatic Cholangiocarcinoma (CASTLE-ZS-01) (NCT06860477) | Fudan University | 2025-03-18 |
| Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R) (NCT07183865) | Fudan University | 2025-03-09 |
| Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions (NCT07362914) | Fudan University | 2025-03-07 |
| Perioperative Immunotherapy for Resectable Limited-Stage SCLC (NCT07109401) | Fudan University | 2025-03-01 |
| Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer (NCT06521866) | Fudan University | 2025-03-01 |
| Predicting Gastric Neoplasia in Patients with High-risk Endoscopic Features (NCT06853509) | Fudan University | 2025-03-01 |
| A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer (NCT06856200) | Fudan University | 2025-02-28 |
| Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer (NCT06763029) | Fudan University | 2025-02-26 |
| IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) (NCT06849986) | Fudan University | 2025-02-25 |
| POLA-R-CHP in the First-line Treatment of Transformed DLBCL (NCT06743945) | Fudan University | 2025-02-17 |
| Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer (NCT06797622) | Fudan University | 2025-02-15 |
| The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer (NCT06738160) | Fudan University | 2025-02-15 |
| Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer (NCT06798506) | Fudan University | 2025-02-15 |
| Reverse HER2-negative Immune Resistant Breast Cancer (NCT06731140) | Fudan University | 2025-02-12 |
| Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast Cancer (NCT07615751) | Fudan University | 2025-02-12 |
| Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT06814067) | Fudan University | 2025-02-10 |
| Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations (NCT07117890) | Fudan University | 2025-02-07 |
| Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients (NCT06795503) | Fudan University | 2025-02-01 |
| CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC (NCT06964568) | Fudan University | 2025-02-01 |
| Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue (NCT07656324) | Fudan University | 2025-01-17 |
| ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs (NCT06775743) | Fudan University | 2025-01-15 |
| Study on the Mechanism of Acquired Resistance of Entrectinib (NCT07199959) | Fudan University | 2025-01-15 |
| Capecitabine in Low Risk Triple Negative Breast Cancer (NCT06787339) | Fudan University | 2025-01-15 |
| Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis (NCT06718933) | Fudan University | 2025-01-08 |
| HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence (NCT06812039) | Fudan University | 2025-01-01 |
| Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial (NCT06965231) | Fudan University | 2025-01-01 |
| Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer (NCT07312500) | Fudan University | 2025-01-01 |
| AI-Enhanced Imaging in Population Breast Cancer Screening (NCT07411443) | Fudan University | 2025-01-01 |
| Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer (NCT07316439) | Fudan University | 2024-12-31 |
| Study of HRS-2189 Combined HRS-5041 in Prostate Cancer (NCT06738745) | Fudan University | 2024-12-31 |
| Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer (NCT06748508) | Fudan University | 2024-12-25 |
| Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer (NCT06636591) | Fudan University | 2024-12-23 |
| BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC (NCT06793332) | Fudan University | 2024-12-17 |
| Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors (NCT06718946) | Fudan University | 2024-12-10 |
| The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer (NCT06718010) | Fudan University | 2024-12-05 |
| First-line Treatment of Advanced/unresectable DDLPS (NCT06694324) | Fudan University | 2024-12-01 |
| Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix. (NCT06705322) | Fudan University | 2024-12-01 |
| A ReaL World Study of DS-8201 (NCT06945224) | Fudan University | 2024-12-01 |
| JAK1 Inhibitor Ivarmacitinib Reversing Immunotherapy Resistance in TNBC (NCT06731153) | Fudan University | 2024-12-01 |
| Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer (NCT06470672) | Fudan University | 2024-12-01 |
| Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer (NCT06684418) | Fudan University | 2024-12-01 |
| SHR-1701 Combined with SHR2554 and BP102 for MCRC (NCT06679673) | Fudan University | 2024-12-01 |
| Evaluating the Efficacy of Structured Exercise Interventions in Alleviating Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors: a Pilot Study Protocol (NCT06754293) | Fudan University | 2024-12-01 |
| Oral Topotecan With Toripalimab for Patients With Endometrial Cancer (NCT06548763) | Fudan University | 2024-11-30 |
| Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer (NCT06601283) | Fudan University | 2024-11-22 |
| Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer (NCT06598033) | Fudan University | 2024-11-22 |
| Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma (NCT06703047) | Fudan University | 2024-11-20 |
| Ivonescimab in the Treatment of Multiple Advanced Tumors (NCT06683846) | Fudan University | 2024-11-20 |
| Selective Neck Dissection Versus Modified Neck Dissection in PTC (NCT06554652) | Fudan University | 2024-11-19 |
| A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor (NCT06682117) | Fudan University | 2024-11-15 |
| HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity (NCT07586215) | Fudan University | 2024-11-11 |
| All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial (NCT06636981) | Fudan University | 2024-11-04 |
| TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC (NCT06676449) | Fudan University | 2024-11-01 |
| Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer (NCT07562711) | Fudan University | 2024-11-01 |
| CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC (NCT06665087) | Fudan University | 2024-11-01 |
| CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC (NCT06652412) | Fudan University | 2024-11-01 |
| Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer (NCT07562503) | Fudan University | 2024-11-01 |
| A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib (NCT06699472) | Fudan University | 2024-10-31 |
| Vaccine Chatbot for Improving Influenza Vaccination Uptake (NCT06657573) | Fudan University | 2024-10-26 |
| Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer (NCT06649331) | Fudan University | 2024-10-21 |
| AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial (NCT06642948) | Fudan University | 2024-10-20 |
| Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy (NCT06090994) | Fudan University | 2024-10-18 |
| Acute Effects of Low Temperature Exposure on Respiratory System (NCT06652932) | Fudan University | 2024-10-16 |
| Acute Effects of Cold Exposure on Cognitive Function (NCT06654167) | Fudan University | 2024-10-16 |
| Acute Effects of Cold Exposure on Cardiovascular System (NCT06652425) | Fudan University | 2024-10-16 |
| Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer (NCT06547736) | Fudan University | 2024-10-14 |
| QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC (NCT06786026) | Fudan University | 2024-10-09 |
| The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer (NCT06635096) | Fudan University | 2024-10-08 |
| To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery (NCT06665334) | Fudan University | 2024-10-01 |
| EMR Versus CSP in the Treatment of Sessile Serrated Lesions Less Than 10mm in Size (NCT06609031) | Fudan University | 2024-10-01 |
| SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt (NCT06588179) | Fudan University | 2024-10-01 |
| ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd (NCT06578286) | Fudan University | 2024-09-30 |
| Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab (NCT06516289) | Fudan University | 2024-09-30 |
| AI-guided Prognostication and Cranial Radiotherapy Optimization in EGFR-TKI-treated Non-small Cell Lung Cancer Patients With Baseline Brain Metastases (NCT06604689) | Fudan University | 2024-09-30 |
| Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy (NCT07067268) | Fudan University | 2024-09-14 |
| RCT on the Neurobehavioral Effects of Fruits and Vegetables in Shanghai Children (NCT06560359) | Fudan University | 2024-09-11 |
| Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma (NCT06583837) | Fudan University | 2024-09-10 |
| Pinoxin for the Prevention of Radiation-Induced Skin Injury (NCT07545720) | Fudan University | 2024-09-05 |
| The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer (NCT06786169) | Fudan University | 2024-09-05 |
| T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer (NCT06548178) | Fudan University | 2024-09-01 |
| A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Cadonilimab Injection and Temozolomide in Second-line and Subsequent Treatment of Advanced Melanoma (NCT06553781) | Fudan University | 2024-09-01 |
| Perioperative Immunotherapy for NSCLC (ECTOP-1030) (NCT06572722) | Fudan University | 2024-09-01 |
| Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer (NCT06552858) | Fudan University | 2024-09-01 |
| Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer (NCT06637150) | Fudan University | 2024-09-01 |
| Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients (NCT06544460) | Fudan University | 2024-08-31 |